Ameet Nathwani, Dewpoint CEO (Viva Technology/Sipa/L.Chamussy, Sipa via AP Images)

Soft­Bank leads $150M round in­to Dew­point as con­den­sate biotech nears clin­ic

In an­oth­er mar­ket, Dew­point Ther­a­peu­tics may have gone pub­lic about now and raised a prince­ly sum.

Al­though they’re still around two years from hu­man tri­als …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.